Suchergebnisse - "Ferro, Antonella"

PubPharm (8)

1

Ten-year survival of neoadjuvant dual HER2 blockade in patients with HER2-positive breast cancer

enthalten in: European journal of cancer (Oxford, England : 1990) | 2023

von Nuciforo, P. | Townend, J. | Piccart, M. | +24

2

Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial

enthalten in: BMC medicine | 2019

von Dieci, M. | Bisagni, G. | Brandes, A. | +29

3

The Promher Study : An Observational Italian Study on Adjuvant Therapy for HER2-Positive, pT1a-b pN0 Breast Cancer

enthalten in: PloS one | 2015

von Gori, S. | Inno, A. | Fiorio, E. | +33

ErratumIn: PLoS One. 2015;10(9):e0139650. - PMID 26406908

4

Circulating tumor cells and response to neoadjuvant paclitaxel and HER2-targeted therapy : a sub-study from the NeoALTTO phase III trial

enthalten in: Breast (Edinburgh, Scotland) | 2013

von Azim, H. | Rothé, F. | Aura, C. | +18

5

CDC25A protein stability represents a previously unrecognized target of HER2 signaling in human breast cancer : implication for a potential clinical relevance in trastuzumab treatment

enthalten in: Neoplasia (New York, N.Y.) | 2013

von Brunetto, E. | Ferrara, A. | Rampoldi, F. | +13

6

PI3KCA mutations and/or PTEN loss in Her2-positive breast carcinomas treated with trastuzumab are not related to resistance to anti-Her2 therapy

enthalten in: Virchows Archiv : an international journal of pathology | 2012

von Barbareschi, M. | Cuorvo, L. | Girlando, S. | +10

7

Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO) : a randomised, open-label, multicentre, phase 3 trial

enthalten in: Lancet (London, England) | 2012

von Baselga, J. | Bradbury, I. | Eidtmann, H. | +105

ErratumIn: Lancet. 2012 Feb 18;379(9816):616 Dosage error in published abstract; MEDLINE/PubMed abstract corrected

8

Increased overall survival independent of RECIST response in metastatic breast cancer patients continuing trastuzumab treatment : evidence from a retrospective study

enthalten in: Breast cancer research and treatment | 2011

von Campiglio, M. | Bufalino, R. | Sandri, M. | +19

1
[1]